Adverse Effects in the Pharmacologic Management of Bipolar Disorder During Pregnancy
| Autor: | Charlotte Hogan, Marlene P. Freeman |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Bipolar Disorder Lithium (medication) medicine.medical_treatment Lamotrigine 03 medical and health sciences 0302 clinical medicine Antimanic Agents Pregnancy Humans Medicine Bipolar disorder Antipsychotic Adverse effect Psychiatry Valproic Acid business.industry Carbamazepine medicine.disease 030227 psychiatry Pregnancy Complications Psychiatry and Mental health Female business 030217 neurology & neurosurgery Antipsychotic Agents medicine.drug |
| Zdroj: | Psychiatric Clinics of North America. 39:465-475 |
| ISSN: | 0193-953X |
| DOI: | 10.1016/j.psc.2016.04.007 |
| Popis: | Management of bipolar disorder during pregnancy often involves medications with potential adverse effects, including risks to the mother and fetus. Although some specifics are known, many medications continue to have incompletely characterized reproductive safety profiles. Women with bipolar disorder who are planning pregnancy face challenging decisions about their treatment; careful risk-benefit discussions are necessary. With the goal of further informing these discussions, this article reviews the data currently available regarding medication safety in the management of bipolar disorder during pregnancy, with specific attention to lithium, valproic acid, lamotrigine, carbamazepine, and antipsychotic medications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|